Most effective vaccines work by inducing a long-lived pool of B cell-derived antibody secreting cells (ASCs) that colonize the bone marrow and produce antibodies (Abs) specific for the vaccine antigens. Although vaccine-induced ASCs provide protection from infection, ASCs can also cause pathology in autoimmune, allergic and transplant patients. Despite the importance of ASCs in protection from infection and in exacerbating chronic disease, we know remarkably little regarding the signals that regulate the development of ASCs from their B cell precursors or the signals that control the lifespan of the ASCs. Therefore, if we wish to manipulate ASC numbers in the settings of both health and disease, there is a need to understand the transcriptional and epigenetic programming events that control commitment to the ASC lineage. There is also a need to identify the microenvironment-derived signals that modulate PC lineage programming so that we can intervene to block or facilitate the development of ASCs with particular functional attributes or lifespans. We recently found that T-bet, an IFN?-induced transcription factor, is expressed by germinal center B cells, ?pre- ASCs? and some, but not all, ASCs. We showed that T-bet regulates ASC development in vitro and in vivo and that T-bet expressing pre-ASCs are induced after vaccination and are expanded in some autoimmune patients. Interestingly, we demonstrated that the IFN? and T-bet regulated ASC developmental pathway is enhanced by IL-21 and repressed by IL-4. Based on these data, the central hypothesis that will be tested in this proposal is that the cytokine microenvironment and the transcription factors induced by those cytokines modulate the epigenetic programming of activated B cells to shape the phenotype, lifespan and functionality of the developing ASCs. The objectives of this proposal are to: (i) determine the molecular and epigenetic basis for T- bet mediated regulation of ASC development, (ii) determine how the cytokine microenvironment modulates ASC development from nave and memory human B cells and (iii) determine how the cytokine microenvironment and cytokine induced transcription factors influence ASC function and lifespan following vaccination. The proposed research is significant because we will, for the first time, mechanistically address how one cytokine-induced transcription factor, T-bet, remodels the epigenetic landscape of developing ASCs and influences their differentiation, function and survival. We will also determine whether we can influence the development, size and quality of the ASC response by altering the cytokine microenvironment. We expect that these studies will not only increase our understanding of the molecular underpinnings of ASC fate decisions, but may also lead to new methodologies to manipulate the development of ASCs in autoimmune and vaccinated individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI125180-03
Application #
9494388
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Tipton, Christopher M; Hom, Jennifer R; Fucile, Christopher F et al. (2018) Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach. Immunol Rev 284:120-131
Upadhyay, Amit A; Kauffman, Robert C; Wolabaugh, Amber N et al. (2018) BALDR: a computational pipeline for paired heavy and light chain immunoglobulin reconstruction in single-cell RNA-seq data. Genome Med 10:20
Jenks, Scott A; Cashman, Kevin S; Zumaquero, Esther et al. (2018) Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity 49:725-739.e6
Haines, Robert R; Barwick, Benjamin G; Scharer, Christopher D et al. (2018) The Histone Demethylase LSD1 Regulates B Cell Proliferation and Plasmablast Differentiation. J Immunol 201:2799-2811
Barwick, Benjamin G; Scharer, Christopher D; Martinez, Ryan J et al. (2018) B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation. Nat Commun 9:1900
Guo, Muyao; Price, Madeline J; Patterson, Dillon G et al. (2018) EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production. J Immunol 200:1039-1052
Sanz, IƱaki (2017) New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research. Arthritis Rheumatol 69:1552-1559
D'Angio, Carl T; Wyman, Claire P; Misra, Ravi S et al. (2017) Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants. Vaccine 35:5163-5171
Tanaka, Toshihiro; Zhang, Weici; Sun, Ying et al. (2017) Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics. Hepatology 66:885-895
Jaworski, Juan Pablo; Bryk, Peter; Brower, Zachary et al. (2017) Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques. PLoS One 12:e0172524

Showing the most recent 10 out of 12 publications